COVID-19 Severity in Multiple SclerosisMaria Pia Sormani, Giovanna Borriello, Paola Cavalla et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 74
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Laura Brambilla, Irene Schiavetti et al.|Multiple Sclerosis Journal|2021Cited by 52
A real‐world study of alemtuzumab in a cohort of Italian patientsCinzia Valeria Russo, Alessio Signori, Francesco Saccà et al.|European Journal of Neurology|2021Cited by 26
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetateMarco Chiarini, Luisa Imberti, Alessandra Sottini et al.|Multiple Sclerosis Journal|2009Cited by 19
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis PatientsFederico Serana, Ruggero Capra, Luisa Imberti et al.|PLoS ONE|2014Cited by 15